4.7 Article

Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects

Journal

DIABETES
Volume 57, Issue 10, Pages 2595-2602

Publisher

AMER DIABETES ASSOC
DOI: 10.2337/db08-0038

Keywords

-

Funding

  1. the American Diabetes Association
  2. the National Institutes of Health [AG030979, DK080157, DK24092, DK067690, HL086089]
  3. the UTHSCSA Executive Research Committee
  4. the South Texas Health Research Center
  5. a Nathan Shock Center Pilot
  6. the U.S Department of Veterans Affairs
  7. the American Heart Association
  8. Faculty of Medicine Siriraj Hospital Mahidol University of Thailand
  9. the Endocrine Fellows Foundation
  10. the Thai Ministry of Public Health [T32 HL007446]

Ask authors/readers for more resources

OBJECTIVE-Tall-like receptor (TLR)4 has been implicated in the pathogenesis of free fatty acid (FFA)-induced insulin resistance by activating inflammatory pathways, including inhibitor of kappa B (I kappa B)/nuclear factor kappa B (NF kappa B). However, it is not known whether insulin-resistant subjects have abnormal TLR4 signaling. We examined whether insulin-resistant subjects have abnormal TLR4 expression and TLR4-driven (I kappa B/NF kappa B) signaling in skeletal muscle. RESEARCH DESIGN AND METHODS-TLR4 gene expression and protein content were measured in muscle biopsies in 7 lean, 8 obese, and 14 type 2 diabetic subjects. A primary human myotube culture system was used to examine whether FFAs stimulate I kappa B/NF kappa B via TLR4 and whether FFAs increase TLR4 expression/content in muscle. RESULTS-Obese and type 2 diabetic subjects had significantly elevated TLR4 gene expression and protein content in muscle. TLR4 muscle protein content correlated with the severity of insulin resistance. Obese and type 2 diabetic subjects also had lower I kappa B alpha content, an indication of elevated I kappa B/NF kappa B signaling. The increase in TLR4 and NF kappa B signaling was accompanied by elevated expression of the NFKB-regulated genes interleukin (IL)-6 and superoxide dismutase (SOD)2. In primary human myotubes, acute palmitate treatment stimulated I kappa B/NF kappa B, and blockade of TLR4 prevented the ability of palmitate to stimulate the I kappa B/NF kappa B pathway. Increased TLR4 content and gene expression observed in muscle from insulin-resistant subjects were reproduced by treating myotubes from lean, normal-glucose-tolerant subjects with palmitate. Palmitate also increased IL-6 and SOD2 gene expression, and this effect was prevented by inhibiting NF kappa B. CONCLUSIONS-Abnormal TLR4 expression and signaling, possibly caused by elevated plasma FFA levels, may contribute to the pathogenesis of insulin resistance in humans.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available